Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-24
2006-01-24
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S048000, C546S070000, C544S233000, C514S248000, C514S285000, C435S184000
Reexamination Certificate
active
06989387
ABSTRACT:
The invention provides compounds of formula I:wherein R1–R9, W, and X have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating cancer using compounds of formula I.
REFERENCES:
patent: 2915523 (1959-12-01), Moore et al.
patent: 2981731 (1961-04-01), Moore et al.
patent: 2985661 (1961-05-01), Hien et al.
patent: 3267107 (1966-08-01), Sallay
patent: 3272707 (1966-09-01), Tedeschi
patent: 3449330 (1969-06-01), Guglielmetti et al.
patent: 3538097 (1970-11-01), Lowe et al.
patent: 3542782 (1970-11-01), Houlihan et al.
patent: 3849561 (1974-11-01), Junzo et al.
patent: 3884911 (1975-05-01), Shimada et al.
patent: 3912740 (1975-10-01), Zee-Chang et al.
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4749708 (1988-06-01), Maroko
patent: 4761417 (1988-08-01), Maroko
patent: 4761477 (1988-08-01), Ikekawa et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4925943 (1990-05-01), Kanmacher et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4980344 (1990-12-01), Maroko
patent: 4992478 (1991-02-01), Geria
patent: 5106863 (1992-04-01), Hajos et al.
patent: 5112532 (1992-05-01), Ninomiya et al.
patent: 5126351 (1992-06-01), Luzzio et al.
patent: 5153178 (1992-10-01), Maroko
patent: 5190753 (1993-03-01), Behrens et al.
patent: 5244903 (1993-09-01), Wall et al.
patent: 5318976 (1994-06-01), Luzzi et al.
patent: 5639759 (1997-06-01), Magolda et al.
patent: 5646283 (1997-07-01), Suzuki et al.
patent: 5767142 (1998-06-01), LaVoie et al.
patent: 5770617 (1998-06-01), LaVoie et al.
patent: 5807874 (1998-09-01), LaVoie et al.
patent: 5981541 (1999-11-01), LaVoie et al.
patent: 6140328 (2000-10-01), LaVoie et al.
patent: 6509344 (2003-01-01), Cushman et al.
patent: 6740650 (2004-05-01), LaVoie et al.
patent: 2004/0110760 (2004-06-01), LaVoie et al.
patent: 2005/0009824 (2005-01-01), LaVoie et al.
patent: 2005/0009825 (2005-01-01), Lavoie et al.
patent: 2005/0009826 (2005-01-01), LaVoie et al.
patent: 2005/0010046 (2005-01-01), LaVoie et al.
patent: 0108147 (1984-05-01), None
patent: 0496634 (1992-07-01), None
patent: 2108955 (1983-05-01), None
patent: 1530628 (1989-12-01), None
patent: WO-92/21661 (1992-12-01), None
patent: WO-96/36612 (1996-11-01), None
patent: WO-97/29106 (1997-08-01), None
patent: WO-98/12181 (1998-03-01), None
patent: WO-98/31673 (1998-07-01), None
patent: WO-99/31067 (1999-06-01), None
patent: WO-00/21537 (2000-04-01), None
patent: WO-01/32631 (2001-05-01), None
patent: WO-03/041660 (2003-05-01), None
patent: WO-03/047505 (2003-06-01), None
patent: WO-2004/014918 (2004-02-01), None
Singh, S.K. et al.: Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones. J. Med. Chem. vol. 46, pp. 2254-2257, 2003.
Andoh, T , et al., “Drug resistance mechanisms of topoisomerase I drugs”,Advances in Pharmacology, 29B, (1994),93-103.
Carmichael, J, “Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing”,Cancer Research, 47(4), (Feb. 15, 1987),936-42.
Chen, Allan Y., “A New Mammalian DNA Topoisomerase I Poison Hoechst 33342: Cytoxicity and Drug Resistance in Human Cell Cultures”,Cancer Research, 53(6), (Mar. 15, 1993), 1332-1337.
Denizot, F., “Rapid colormetric assay for cell growth and survival—Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability”,Journal of Immunological Methods, 89 (2), (May 22, 1986),271-277.
Fujii, Noboru, et al., “Induction of Mammalian DNA Topoisomerase I-mediated DNA Cleavage and DNA Winding by Bulgarein”,Journal of Biological Chemistry, 268(18), (Jun. 25, 1993), 13160-13165.
Gatto, Barbara, “Identification of Topoisomerase I as the Cyctotoxic Target of the Protoberberine Alkaloid Coralyne”,Cancer Research, 56(12), (Jun. 15, 1996),2795-2800.
Kim, Jung S., “Substituted 2,5′-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity”,Journal of Medicinal Chemistry, 39(4), (Feb. 16, 1996), 992-998.
Makhey, Darshan, “Coralyne and Related Compounds as Mammalian Topoisomerase I and Topoisomerase II Poisons”,Bioorganic&Medicinal Chemistry, 4(6), (Jun. 1996),781-791.
Makhey, Darshan, “Protoberberine Alkaloids and Related Compounds as Dual Inhibitors of Mammalian Topoisomerase I and II”,Medicinal Chemistry Research, 5(1), (1994), 1-12.
Maniatis, Tom, “Molecular cloning :a laboratory manual”,Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, (1982), 149-185.
Mosmann, T., “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays”,Journal of Immunological Methods, 65(1-2), (Dec. 16, 1983),55-63.
Singh, S. K., et al., “Nitro and Amino Substitution in the D-Ring of 5-(2-Dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo [c,h] [1,6] naphthyridin-6-ones: Effect on Topoisomerase-I Targeting Activity and Cytotoxicity”,Journal of Medicinal Chemistry46(11), (2003),2254-2257.
Stermitz, Frank R., “Synthesis and Biological Activity of Some Antitumor Benzophenanthridinum Salts”,Journal of Medicinal Chemistry, 18(7), (Jul. 1975),708-713.
Sun, Q , et al., “Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors”,Journal of Medicinal Chemistry, 38(18), (Sep. 1, 1995), 3638-44.
Tewey, K M., et al., “Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II”,Science, 226(4673), (Oct. 26, 1984), 466-8.
Wang, H , et al., “Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation”,Biochemistry, 40(11), (Mar. 20, 2001),3316-23.
Yamashita, Yoshinori , et al., “Induction of Mammalian DNA Topoisomerase I and II Mediated DNA Cleavage by Saintopin, a New Antitumor Agent from Fungus”,Biochemistry, 30(24), (Jun. 18, 1991),5838-5845.
Yamashita, Yoshinori , “Induction of Mammalian DNA Topoisomerase I Mediated DNA Cleavage by Antitumor Indolocarbazole Derivatives”,Biochemistry, 31(48), (Dec. 8, 1992), 12069-12075.
Akiyama, Shin-Ichi , et al., “Isolation and Genetic Characterization of Human KB Cell Lines Resistant to Multiple Drugs”,Somatic Cell and Molecular Genetics, 11(2), (1985), 117-126.
Andoh, Toshiwo , et al., “Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I”,Proceedings of the National Academy of Sciences USA, 84(16), (1987),5565-5569.
Aquirre, J. M., et al., “Reaction of 1,2-diarylethylamides with ethyl polyphosphate(EPP): correlation of the von Braun, Ritter and Bischler-Napieralski reactions.”,Chemical Abstracts, 111(13), Abstract No. 115004, (1989),646.
Arumugam, N. , et al., “Synthesis of 7,8-Benzophenanthridines”,Indian Journal of Chemistry, vol 12, (1974),664-667.
Badia, Dolores , et al., “Silicon-mediated isoquinoline synthesis: preparation and stereochemical characterization of 4-hydroxy-3-phenylisoquinolines”,Chemical Abstracts, 117(13), Abstract No. 131034,(1992),730.
Baezner, C. , et al., “Uberfuhrung von o-nitro- und o,p-dinitro-benzylchlorid in acridinderivate”,Berichte der Deutschen Chemischen Gesellschaft, 39, English Title—Conversion of i-nitro and o,p-dinitrobenzylchlroide into acridinic derivatives,(1906),2438-2447.
Baezner, Carlo , “Uberfuhrung von o-nitround o, p-dinitro-benzylchlorid in acridinderivate”,Berichte der Deutschen Chemischen Gesellschaft, 37, English Title—Conversion of o-nitrobenzyl chloride and o,p-dinitrobenzyl chloride into acridine derivatives,(1904),3077-3083.
Bhakuni, D. S., et al., “Protoberberine Alkaloids&#
LaVoie Edmond J.
Liu Leroy F.
Singh Sudhir K.
Aulakh Charanjit S.
Rutgers The State University of New Jersey
Viksnins Harris & Padys PLLP
LandOfFree
Nitro and amino substituted topoisomerase agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitro and amino substituted topoisomerase agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitro and amino substituted topoisomerase agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3570016